Lai Wang

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

Constantine S. Tam, Judith Trotman, Stephen Opat et al. · Blood · 2019 · 355 citations · Full text

Inhibition of Human Immunodeficiency Virus Type 1 Transcription by Chemical Cyclin-Dependent Kinase Inhibitors

Dai Wang, Cynthia de la Fuente, Longwen Deng et al. · Journal of Virology · 2001 · 133 citations · Full text

The BTK Inhibitor, Bgb-3111, Is Safe, Tolerable, and Highly Active in Patients with Relapsed/ Refractory B-Cell Malignancies: Initial Report of a Phase 1 First-in-Human Trial

Constantine S. Tam, Andrew Grigg, Stephen Opat et al. · Blood · 2015 · 111 citations

Autophagy occurs upstream or parallel to the apoptosome during histolytic cell death

Fatih Akdemir, Róbert Farkas, Po Chen et al. · Development · 2006 · 101 citations · Full text

Cell Autophagy, Mitophagy, Signal Transduction +15

Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development

Hexiang Wang, Bo Ren, Ye Liu et al. · Journal of Medicinal Chemistry · 2020 · 69 citations · Full text